AEON Biopharma, Inc. (AEON) stock
AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.11−0.03 (-19.40%)
Close on Nov 17, 2026Market cap $5.66MP/E –Yield –
AEON Biopharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
AEON Biopharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.64M. For fiscal 2025 it was -$17.31M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.31M | – |
| FY2024 | Dec 31, 2024 | -$20.29M | – |
| FY2022 | Dec 31, 2022 | -$35.58M | – |
| FY2021 | Dec 31, 2021 | -$1.49M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.70M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.64M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.71M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.60M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.91M | – |
| Q4 FY2024 | Dec 31, 2024 | -$621.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.96M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.12M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.60M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.09M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.06M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.56M | – |
| Q2 FY2022 | Jun 30, 2022 | -$158.49K | – |
| Q1 FY2022 | Mar 31, 2022 | -$411.67K | – |
| Q4 FY2021 | Dec 31, 2021 | -$162.63K | – |
| Q3 FY2021 | Sep 30, 2021 | -$325.32K | – |
| Q2 FY2021 | Jun 30, 2021 | -$452.32K | – |
| Q1 FY2021 | Mar 31, 2021 | -$554.52K | – |
See a number that looks wrong?